Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Important role of mast cells in multiple sclerosis.
IL-17A and multiple sclerosis: signaling pathways, producing cells and target cells in the central nervous system.
The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
Robust myelin quantitative imaging from multi-echo T2 MRI using edge preserving spatial priors.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
Novartis: CHMP Issues Positive Opinion To Expand EU Label For Gilenya In RRMS
The Relationship Between Quality of Life and Dysarthria in Patients with Mutliple Sclerosis.
Study of type a and B behavior patterns in patients with multiple sclerosis in an Iranian population.
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.
Protective Autoimmunity: A Unifying Model for the Immune Network Involved in CNS Repair.
IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.
Autophagy Is Required for Neutrophil-Mediated Inflammation.
Short-Term Effect of High-Dose Vitamin D on the Level of Interleukin 10 in Patients with Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography.
Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
Utilization of physical rehabilitation among people with multiple sclerosis.
Characteristics of flow through the internal jugular veins at cervical C2/C3 and C5/C6 levels for multiple sclerosis patients using MR phase contrast imaging.
TIP30 inhibits oligodendrocyte precursor cell differentiation via cytoplasmic sequestration of Olig1.
Identification of cortical lesions using DIR and FLAIR in early stages of multiple sclerosis.
Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors.
Small-molecule Klotho enhancers as novel treatment of neurodegeneration.
Regulation of the vitamin D receptor gene by environment, genetics and epigenetics.
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.
Methods for Ex Vivo Analysis of Immune Cell Function from the Central Nervous System.
Pages
« first
‹ previous
…
443
444
445
446
447
448
449
450
451
…
next ›
last »